The ongoing government shutdown is causing uncertainty for farmers, freezing critical aid and potentially leading to volatile ...
(“CSPC”) (Stock Code: 1093.HK) jointly announced that biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted another breakthrough therapy designation by the Center for Drug ...
October 2025 Tezspire approved in the US for chronic rhinosinusitis with nasal polyps Approval broadens indication for Tezspire to a second disease characterised by epithelial-driven inflammationAstra ...
Nostalgic but fresh, familiar yet novel. These qualities, plus detailed worldbuilding, have been trademarks of Dan Pepperell, ...
In today's edition of Illinois in Focus Daily, The Center Square Editor Greg Bishop shares President Donald Trump's reaction ...
Amazon says its systems are back online again after connectivity issues persisted Monday. But reports of problems with Amazon’s cloud computing services unit AWS continue.
In a Phase III trial, sacituzumab tirumotecan outperformed chemo in previously treated EGFR-mutant NSCLC patients, results presented at the ESMO Congress show.
India procured 80 per cent of the full courses of studied antibiotics but managed to treat only 7.8 per cent of its estimated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback